National Coverage Analysis (NCA) Tracking Sheet

Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)



Per Section 1861(ddd) of the Social Security Act and implementing regulations at 42 CFR 410.64, CMS may cover "additional preventive services", if it determines through the national coverage determinations (NCD) process that the service is recommended with a grade A (strongly recommends) or grade B (recommends) rating by the United States Preventive Services Task Force (USPSTF) and that it also meets certain other requirements.

The USPSTF recently published an updated recommendation with a grade B for certain persons at high risk for lung cancer based on age and smoking history for screening for lung cancer with low dose computed tomography (LDCT).

CMS received a complete, formal request to reconsider the NCD.

CMS is soliciting public comment relevant to the reconsideration. We are particularly interested in comments that include scientific evidence and that address the breadth of the request.

Benefit Category

Additional Preventive Services

Requestor Information

Requestor Name Requestor Letter
GO2 Foundation for Lung Cancer, The Society of Thoracic Surgeons, and American College of Radiology® (ACR®) View Letter

Important Dates

Formal Request Accepted and Review Initiated
Expected NCA Completion Date
Public Comment Period
05/18/2021 - 06/17/2021
Proposed Decision Memo Due Date
Proposed Decision Memo Released
Proposed Decision Memo Public Comment Period
11/17/2021 - 12/17/2021
Decision Memo Released
Comments for this NCA
View Public Comments


Lead Analysts
Kimberly Long
Lead Medical Officers
Carl Li, M.D.

Medicare Benefit Category Determination Date

Actions Taken

May 18, 2021

CMS initiates this national coverage analysis for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). The initial 30-day public comment period begins with this posting date, and ends after 30 calendar days. CMS considers all public comments, and is particularly interested in clinical studies and other scientific information relevant to the topic under review.

Instructions on submitting comments can be found at:

To submit a comment, please use the orange "Comment" button at the top of the page. Enter comments directly into the “Submit A Public Comment” webpage.

November 17, 2021

February 10, 2022